ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

214
Analysis
Health CareSouth Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
Refresh
21 Aug 2023 00:37

Merger Arb Mondays (21 Aug) - Costa, OreCorp, Sanei, T&K Toka, Celltrion, Eoflow, Golden Eagle

This week, the highest gross spreads are 111 (24.9%), Symbio (14.8%), ENM (11.5%), Eoflow (11.1%), Orecorp (9.3%), Mason (9.0%), Costa (7.6%), Poly...

Logo
330 Views
Share
20 Aug 2023 07:19

Index Rebalance & ETF Flow Recap: ASX, NEXT50, MVMVA, MVMVW, Celltrion, Brilliance, KQ150, HSCI

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
468 Views
Share
bullishCelltrion Inc
20 Aug 2023 07:00

(Mostly) Asia-Pac Weekly Risk Arb Wrap: Celltrion, Sanei Architecture, T&K Toka, MPI, Chindata

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
377 Views
Share
bullishCelltrion Inc
16 Jul 2023 07:00

Last Week in Event SPACE: Celltrion, Fast Retailing, Canon, Costa, Chindata

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
389 Views
Share
bearishCelltrion Inc
13 Jul 2023 08:34

Celltrion Merger Announcement in July: Trading Angles Utilizing Appraisal Rights Exercise Dynamics

Following the news that Celltrion has chosen Mirae Asset Securities as the primary underwriter for its merger plans, there has been a notable surge...

Logo
1.1k Views
Share
x